Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05693896 · ClinicalTrials.gov registry record · NA

Treating Binge Eating and Obesity Digitally in Black Women

A NA study of Obesity and Binge-Eating Disorder, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05693896: Recruiting NA study of Obesity and Binge-Eating Disorder, sponsored by University of North Carolina, Chapel Hill.

NCT05693896 is a NA study of Obesity and Binge-Eating Disorder that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05693896, a NA study of Obesity and Binge-Eating Disorder, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

More than 30% of Black women with obesity binge eat. Binge eating may increase the risk for the development of metabolic syndrome and binge-eating-disorder (BED), which is associated with severe obesity. Though several effective treatments for binge eating exist, Black women have not fared well. Not only has their inclusion in treatment trials been limited, but when participating, they are more likely to drop out, and/or lose less weight, compared to their White counterparts. Furthermore, treatment for binge eating is often not available in primary care and community-based settings places where Black women are more likely to receive treatment for their eating and weight-related concerns. Currently, there is scant intervention research to treat binge eating in Black women. With the highest rates of obesity (57%) nationally, Black women are in need of culturally-relevant treatments for binge eating and weight gain prevention. Given the established relationship between frequent binge eating and subsequent weight gain, addressing binge eating among Black women with obesity is imperative.

Primary Outcome

Recruitment is defined as the number of potential eligible adults screened for the study versus the number of persons who enrolled in the study.

Interventions

  • BEHAVIORAL Centering Appetite

Study Locations (1)

North Carolina

  • UNC-Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-01-15
Est. Completion 2026-12
Phase NA

What NCT05693896 shows while recruiting

NCT05693896 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Centering Appetite is the first listed.

NCT05693896 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05693896 about?

NCT05693896 is a clinical study titled "Treating Binge Eating and Obesity Digitally in Black Women". More than 30% of Black women with obesity binge eat. Binge eating may increase the risk for the development of metabolic syndrome and binge-eating-disorder (BED), which is associated with severe obesity. Though several effective treatments for binge eating exist, Black women have not fared well. Not...

What is the current status of trial NCT05693896?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-01-15. Estimated completion is 2026-12.

What conditions does trial NCT05693896 study?

This clinical trial studies the following conditions: Obesity, Binge-Eating Disorder, Binge Eating, Weight Gain Prevention.

What interventions are being tested in trial NCT05693896?

The interventions under investigation include: Centering Appetite (BEHAVIORAL).

Who is sponsoring clinical trial NCT05693896?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05693896 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05693896's enrollment target sits among peer trials

60 642nd of 1053 higher than 374 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05693896, the US trial registry maintained by the National Library of Medicine. NCT05693896 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.